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Rapid ultrasonic isothermal amplification of DNA
with multiplexed melting analysis – applications
in the clinical diagnosis of sexually transmitted
diseases†
Gaolian Xu,a Rory N. Gunson,b Jonathan M. Coopera and Julien Reboud*a
We describe a nucleic acid testing (NAT) platform for infectious
disease diagnostics at the point-of-care, using surface acoustic
waves (SAW) to perform a multiplexed loop-mediated isothermal
amplification (LAMP) test for sexually transmitted diseases. The
ultrasonic actuation not only enables faster NAT reactions but also
provides a route towards integrating low-cost, low-power molecular
diagnostics into disposable sensors.
Infectious diseases cause more than half of the deaths in low
resource countries.1 To reduce the impact of these diseases, it
is now broadly accepted that early diagnosis is needed in order
to break the cycle of infection and transmission, reducing both
mortality and morbidity. The development of rapid, high
performance molecular diagnostic technologies, such as those
involved in NATs has the potential to provide a much-needed
step change, enabling the early diagnosis of infection.2
Currently NATs can provide information on themicrobial species
and sub-types, enabling, for example, the identification of drug
resistant strains. However, existing technologies suffer from limita-
tions in both speed and cost.2 They also often require considerable
user expertise. To date the majority of these have been based upon
the polymerase chain reaction (PCR), an amplification method
which although widely used, is also difficult to implement in
resource limited areas.2 As an alternative loop mediated isothermal
amplification (LAMP) can amplify DNA at a constant temperature
(60–65 1C), enabling detection with both high sensitivity and speci-
ficity.3 The technique has previously been demonstrated for patho-
gen detection, such as Mycobacterium tuberculosis4 and HIV,5 and
has led to its adoption by important stakeholders such as FIND.6
Recently, LAMP amplification has also been integrated within
microfluidic devices to enable small volume analysis and
enhance portability.7 Real-time sensing has also been performed
using both fluorescence3 and turbidity (which can be seen with
the naked eye, but does not enable multiplexing).8
Surface acoustic waves (SAW) are most commonly generated
with an interdigitated transducer (IDT) patterned on the surface of a
piezoelectric substrate. The energy in the associated ultrasonic wave
is located at the chip surface, in this case at its interface with the
sample, positioned in the propagation pathway (Fig. 1).9 Upon
reaching the liquid, the SAW refracts and depending upon the
power and frequency, the energy can be used for a range of
microfluidic functions, including heating and mixing.10 We have
previously shown that SAWs can be coupled into a disposable chip
and then used to perform sample processing of blood,11 to control
aggregation of colloids,12 to concentratemicro-organisms in blood13
and integrate PCR assays onto a low-cost low-power system.14
In this paper, we demonstrate the integration of SAW-
induced heating to perform real-time LAMP using EvaGreent
fluorescent DNA-intercalating dye system.15 We first charac-
terised the sensitivity of the technique for the detection of
Chlamydia trachomatis (CT), demonstrating limits of detection
of ten copies of the CT target per sample (established using a
serial dilution). We also showed for the first time that SAW-
induced amplification provides a new method to enable multi-
plexed detection, using melting curve analysis to simultaneously
detect Neisseria gonorrhoea (GC) and CT. The LAMP reaction was
performed at a constant temperature, without the requirement for
precise control of thermal cycles. As a consequence, we demon-
strated an integrated assay protocol with greatly reduced reaction
times and a simplified operational control. Interestingly, the use of
acoustic actuation results in streaming flows that speed up the LAMP
reaction, when compared to electrical heating, by as much as 20%.
The assay was developed on a disposable chip by in-coupling
the SAWs propagated at 20 MHz (3.0 MHz), from a LiNbO3
piezoelectric substrate. The sample was a 4.0 mL drop of LAMP
mix (see supplementary methods in ESI† for details on the
reagents and DNA sequence designs), encapsulated in mineral
oil to prevent evaporation (Fig. 1A). Heat was generated using the
SAW and temperature changes were monitored, for purposes of
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characterisation and calibration using infrared imaging
(Fig. S1 in ESI†). An actuation power (ca. 1.2 W) was used to
stabilise the temperature of the sample at 60 1C (Fig. S1 in
ESI† – temperature stability). As amplification took place, the
EvaGreent fluorescent dye was incorporated into the double-
stranded DNA, with a resulting exponential increase in the
signal intensity, Fig. 1B.
The fluorescence intensity of the non-template negative
control (no target) remained constant throughout the assay,
indicative of no non-specific amplification (Fig. 1B). After 20 min,
the efficiency of the fluorescent dye diminished, resulting in a
decrease in the intensity of the signal. Gel electrophoresis of the
amplified target confirmed a positive amplification using both
SAW (Lane 1) and Peltier actuated heating (Lane 2) with no non-
specific signal for the negative samples (Lanes 3 and 4), Fig. 1B
(inset). We further showed the specificity of the reaction and its
applicability to clinical diagnostics by processing two residual GC
positive patient samples (obtained as swabs and extracted as part
of routine clinical diagnostics at the NHS West of Scotland
Specialist Virology Centre – Fig. S3 in ESI†). The analysis of the
samples demonstrate the specificity of the CT SAW LAMP assay,
as no non-specific signal can be seen.
To provide a figure of merit for the sensitivity, we serially
diluted the CT DNA target (the cryptic plasmid gene of CT,16
using the primer set of Table S1 in ESI†) from 105 to 10 copies
per reaction. Fig. 2A shows normalised real-time amplification
curves for each concentration. As the copy number was decreased,
the exponential phase of signal enhancement started later as a
consequence of the reaction kinetic (from ca. 6 min for 105 copies
to ca. 22 min for 10 copies, Fig. 2A).
To demonstrate the efficiency and speed of the SAW-
actuated assay, we defined a threshold time (Tt) as the reaction
time for the fluorescence signal to reach 50% of the maximum
(this new figure of merit is analogous to the cycle threshold (Ct)
of real-time PCR).17 Fig. 2B shows that, as the target concen-
tration was increased, Tt decreases linearly with the log of the
target concentration.18 The precise nature of this relationship is
Fig. 1 (A) Integrated SAW-LAMP device. The SAW generated by the IDT
patterned on the piezoelectric surface was coupled into a superstrate.
A 4.0 mL droplet of the LAMP mix was dispensed on the superstrate and
covered with mineral oil to prevent evaporation. (B) Real time results of
SAW-LAMP: (1) black triangle, positive amplification (103 copies per reaction);
(2) red circles, negative amplification (non-template signal). The target gives
an amplification after B8 min, while the negative sample shows a constant
signal. (inset) Electropherograms of SAW-LAMP of CT: Lane M: DNA marker
(100 bp ladder – Promega G2101); Lane 1: SAW-LAMP positive; Lane 2: LAMP
(positive) with thermal heating actuation using a Peltier heater; Lane 3: SAW-
LAMP non-template negative control; Lane 4: LAMP non-template negative
with thermal heating actuated using a Peltier heater.
Fig. 2 (A) Real-time amplification curve of SAW LAMP of serial 10-fold diluted
CT positive template (1–5 normalised real-time amplification curves, left axis),
and ddH2O as a negative control (6, right axis, not normalised to ease read-
ability): (1) 105 copies per reaction (black square); (2) 104 copies per reaction
(red circle); (3) 103 copies per reaction (blue up-triangle); (4) 102 copies per
reaction (green triangle); (5) 10 copies per reaction (magenta diamond).
(6) Negative control (olive pentagon). As the concentration increases, the
amplification is initiated earlier, evidenced by the exponential increase in the
fluorescence. (B) Threshold time (defined as the time corresponding to 50% of
the maximum fluorescence intensity, Tt) as a function of target concentration,
(1) Peltier-based LAMP (red disks) and (2) SAW LAMP (dark square). Data is the
average of at least 3 replicates and error bars represent the standard deviation.
The data was fitted with linear regression (R24 0.98).
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important as it enables us to quantify the amount of target
DNA present in the sample, prior to LAMP amplification. The
divergent gradients of the linear regressions in Fig. 2B indicate
the relative difference in speed of the SAW and the Peltier-
based assays. SAW induced streaming enhanced the speed of
response (SAW-based LAMP were on average 18.2%  2.5 faster
than the Peltier system, Fig. 2B) providing a clear analytical
advantage for assays that require higher sensitivities. It is
particularly relevant to note that the response time of a point-
of-care diagnostic assay and consequently the time that patients
wait for a result is critical in compliance in both screening and
point-of-care testing.19 This is especially relevant for sexually
transmitted infection (STI) testing, where detecting low copy
numbers quickly, is critical to avoid complications, especially in
asymptomatic infected (sub-clinical) patients, by enabling early
diagnosis and treatment.20
GC and CT are two of the most common bacterial STIs,20
and a multiplexed assay would therefore not only provide an
improved clinical outcome for the individual (as patients are
often co-infected with both pathogens), but would also reduce
the overall levels of the diseases in the population. To enable
multiplexing, we used the amplicons’ different melting tem-
peratures to distinguish between the two diseases. We first
established the specificity of each singleplex reaction, using
melting analysis, for each pathogen, whilst ramping the tem-
perature between 60 1C and 90 1C (Fig. 3A). The specific melting
temperature was defined as the inflexion point at which dF/dT
reaches a minimum (where F is the fluorescence intensity and
T is temperature), Fig. 3C. The melting temperature of CT
amplicons obtained using SAW actuation was 79.65  0.14 1C,
whilst that for GC was 83.55  0.53 1C (Fig. 3B). An example of
differentiated curves is available as Fig. S2 in ESI.†
By combining amplicons from both target pathogens in the
same sample, we were able to use the melting curves to provide
a multiplexed SAW LAMP assay, Fig. 3C. The difference between
the melting temperatures for each pathogen was sufficiently
large to distinguish between the targets (Student’s T-test P4 0.95),
enabling the diagnosis of both diseases simultaneously. This
technique is currently limited by the availability of amplicons
with significantly different melting temperatures.21 In future,
multiplexing could be further extended through the use of more
complex strategies such as high resolution melting (HRM).22
Despite challenges in combining a high number of primers in a
single reaction (6 per target), previously it has been shown that
specific strategies can enabled the multiplexing of up to four
different targets in one sample.23
In conclusion, we show for the first time that acoustic
actuation using SAW can be used to perform highly sensitive
and specific multiplexed LAMP-based amplification of patho-
gen DNA (with a limit of detection down to 10 copies) with
enhanced speeds. The strategy for multiplexing enables single
colour detection, thereby simplifying the control and design of
the instrumentation. This ease of implementation, coupled
with the use of low-power, mass manufacturable SAW devices,14
provides the potential to significantly impact upon near patient
diagnostics.
This work was supported by a College of Science and
Engineering Studentship (GX, Glasgow, UK), a Lord Kelvin and
Adam Smith Research Fellowship (JR, Glasgow, UK), an EPSRC
fellowship (JC, EP/K027611/1), an ERC Advanced Investigator
Award (JC), and an NHS Partnership award (JC, JR, RG). The authors
thank the James Watt Nanofabrication Centre (Glasgow, UK) for
help in device fabrication and David Paterson (Glasgow, UK) for
illustration.
Notes and references
1 D. M. Morens, G. K. Folkers and A. S. Fauci, Nature, 2010, 463, 122.
2 R. McNerney and P. Daley, Nat. Rev. Microbiol., 2011, 9, 204–213.
3 T. Notomi, H. Okayama, H. Masubuchi, T. Yonekawa, K. Watanabe,
N. Amino and T. Hase, Nucleic Acids Res., 2000, 28, e63–e63.
4 T. Iwamoto, T. Sonobe and K. Hayashi, J. Clin. Microbiol., 2003, 41,
2616–2622.
5 N. Hosaka, N. Ndembi, A. Ishizaki, S. Kageyama, K. Numazaki and
H. Ichimura, J. Virol. Methods, 2009, 157, 195–199.
6 N. Zablon Kithinji, PLoS Neglected Trop. Dis., 2012, 6, e1572.
7 K. Hsieh, A. S. Patterson, B. S. Ferguson, K. W. Plaxco and H. T. Soh,
Angew. Chem., Int. Ed., 2012, 51, 4896–4900.
Fig. 3 LAMP product melting analysis using EvaGreent. (A) Shows the melt-
ing curves of CT and GC as singleplexes. As the temperature was increased
from 60 1C to 90 1C, the double stranded DNA became single stranded,
causing the decrease of fluorescence intensity. The number 1–4 in A1/A2 show
the different targets: (1) CT positive (103 copies per reactions); (2) GC positive
(103 copies per reactions); (3) GC negative (ddH2O); (4) CT negative (ddH2O).
(B) Shows the melting temperature of CT and GC. Data is the average of a
minimum of 3 repeats and error bars represent the standard deviation.
(C) CT/GC multiplex reaction with different target. (C) Shows the relationship
between dF/dT and temperature, where F is the fluorescence intensity and
T is the temperature. (1) Negative (ddH2O); (2) GC positive only (10
3 copies per
reactions); (3) GC/CT positive (103 copies per reactions); (4) CT positive only
(103 copies per reactions).
ChemComm Communication
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
D
ec
em
be
r 2
01
4.
 D
ow
nl
oa
de
d 
on
 0
6/
03
/2
01
5 
11
:1
5:
40
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
2592 | Chem. Commun., 2015, 51, 2589--2592 This journal is©The Royal Society of Chemistry 2015
8 Y. Mori, M. Kitao, N. Tomita and T. Notomi, J. Biochem. Biophys.
Methods, 2004, 59, 145–157.
9 A. Wixforth, Spec. Issue Dedic. Profr. Jorg Kotthaus Occas. His 60th Birthd.
29th May 2004, 2003, 33, 389–396.
10 X. Ding, P. Li, S.-C. S. Lin, Z. S. Stratton, N. Nama, F. Guo,
D. Slotcavage, X. Mao, J. Shi, F. Costanzo and T. J. Huang, Lab Chip,
2013, 13, 3626–3649.
11 J. Reboud, Y. Bourquin, R. Wilson, G. S. Pall, M. Jiwaji, A. R. Pitt,
A. Graham, A. P. Waters and J. M. Cooper, Proc. Natl. Acad. Sci. U. S. A.,
2012, 109, 15162–15167.
12 J. Reboud, C. Auchinvole, C. D. Syme, R. Wilson and J. M. Cooper,
Chem. Commun., 2013, 49, 2918–2920.
13 Y. Bourquin, A. Syed, J. Reboud, L. C. Ranford-Cartwright, M. P.
Barrett and J. M. Cooper, Angew. Chem., Int. Ed., 2014, 53,
5587–5590.
14 Z. Guttenberg, H. Muller, H. Habermuller, A. Geisbauer, J. Pipper,
J. Felbel, M. Kielpinski, J. Scriba and A. Wixforth, Lab Chip, 2005, 5,
308–317.
15 Y.-M. Qiao, Y.-C. Guo, X.-E. Zhang, Y.-F. Zhou, Z.-P. Zhang, H.-P. Wei,
R.-F. Yang and D.-B. Wang, Biotechnol. Lett., 2007, 29, 1939–1946.
16 K. Jaton, J. Bille and G. Greub, J. Med. Microbiol., 2006, 55, 1667–1674.
17 R. Higuchi, C. Fockler, G. Dollinger and R. Watson, Nat. Biotechnol.,
1993, 11, 1026–1030.
18 F. Ahmad, G. Seyrig, D. Tourlousse, R. Stedtfeld, J. Tiedje and
S. Hashsham, Biomed. Microdevices, 2011, 13, 929–937.
19 G. J. Kost, N. K. Tran, M. Tuntideelert, S. Kulrattanamaneeporn and
N. Peungposop, Am. J. Clin. Pathol., 2006, 126, 513–520.
20 S. B. Lyss, M. L. Kamb, T. A. Peterman, J. S. Moran, D. R. Newman,
G. Bolan, J. M. Douglas, M. Iatesta, C. K. Malotte, J. M. Zenilman,
J. Ehret, C. Gaydos and W. J. Newhall, Ann. Intern. Med., 2003, 139,
178–185.
21 J. Mahony, S. Chong, D. Bulir, A. Ruyter, K. Mwawasi and D. Waltho,
J. Clin. Microbiol., 2013, 51, 2696–2701.
22 D. C. T. Ong, W.-C. Yam, G. K. H. Siu and A. S. G. Lee, J. Clin.
Microbiol., 2010, 48, 1047–1054.
23 N. A. Tanner, Y. Zhang and T. C. Evans, BioTechniques, 2012, 52, 81–89.
Communication ChemComm
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
D
ec
em
be
r 2
01
4.
 D
ow
nl
oa
de
d 
on
 0
6/
03
/2
01
5 
11
:1
5:
40
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
